Navidea Biopharmaceuticals Announces Closing of its Rights Offering and Second Quarter 2022 Earnings Conference Call and Business Update
Stock Information for Navidea Biopharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.